Tag: Lotus
Simultaneous TAVI and left atrial appendage closure is feasible
Thomas S Gilhofer (University Heart Center, Department of Cardiology, University Hospital Zurich...
EuroPCR 2018: Boston Scientific outlines its key presentations
Boston Scientific Corporation has revealed its schedule of key presentations—including two late-...
PCR LV 2017: Refining implantation technique and device iterations may improve pacemaker rate seen with Lotus
New data from REPRISE III indicate that keeping the bottom of the frame at annular level while i...
EuroPCR 2017: Lotus TAVI device has superior efficacy to CoreValve at one year
Data from the REPRISE III trial indicate that the Lotus transcatheter aortic valve implantation (TAV...
Locking mechanism problems prompt Boston Scientific to recall all ranges of its Louts TAVI device
According to Reuters, Boston Scientific is recalling all ranges of its transcatheter aortic valv...
Boston Scientific closes acquisition of certain Neovasc assets
Boston Scientific Corporation has closed its acquisition of certain manufacturing assets and cap...
Boston Scientific to acquire Neovasc biological tissue capabilities
Boston Scientific has agreed to acquire certain manufacturing assets and capabilities of the Neo...
PCRLV 2016: Next-generation of Lotus TAVI receives CE mark
Coinciding with PCR London Valves (18-20 September, London, UK), Boston Scientific has announced...
Boston Scientific issues urgent recall of Lotus systems manufactured prior to March 2016.
Boston Scientific has sent a letter to its customers notifying them that it is implementing a “v...
